ISOLATION AND CHARACTERISATION OF RESISTANT HERPES SIMPLEX VIRUS AFTER ACYCLOVIR THERAPY
- 1 February 1982
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 319 (8269), 421-423
- https://doi.org/10.1016/s0140-6736(82)91620-8
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Acyclovir Prophylaxis of Herpes-Simplex-Virus InfectionsNew England Journal of Medicine, 1981
- ACYCLOVIR THERAPY FOR MUCOCUTANEOUS HERPES SIMPLEX INFECTIONS IN IMMUNOCOMPROMISED PATIENTSThe Lancet, 1981
- CONTROLLED CLINICAL TRIAL OF INTRAVENOUS ACYCLOVIR IN HEART-TRANSPLANT PATIENTS WITH MUCOCUTANEOUS HERPES SIMPLEX INFECTIONSThe Lancet, 1981
- Isolation and Characterization of Acyclovir-resistant Mutants of Herpes Simplex VirusJournal of General Virology, 1980
- Resistance of herpes simplex virus to acycloguanosine: role of viral thymidine kinase and DNA polymerase loci.Proceedings of the National Academy of Sciences, 1980
- Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1.Proceedings of the National Academy of Sciences, 1980
- Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivoAntimicrobial Agents and Chemotherapy, 1980
- PARENTERAL ACYCLOVIR THERAPY FOR HERPESVIRUS INFECTIONS IN MANThe Lancet, 1979
- Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine.Journal of Biological Chemistry, 1978
- Dye Uptake Methods for Assessing Viral Cytopathogenicity and their Application to Interferon AssaysJournal of General Virology, 1969